Syneron (NASDAQ: ELOS) develops, manufactures and markets medical aesthetic devices based on the ELOS combined energy technology (Electro-Optical Synergy) using Bi-Polar Radio Frequency and Light. The company’s products have superior safety features comparing to other devices on the market, with equal or even better efficacy.

ColBar (acquired by Johnson & Johnson) is a biomaterials company specializing in reconstructive medicine and tissue engineering.

XTL (NASDAQ:XTLB; TASE: XTL) is developing therapeutics for the treatment of diabetic neuropathic pain and HCV

Mazor (TASE: MZOR) is developing, manufacturing and marketing products in the orthopedic minimally invasive surgery market (particularly the spine market), based on a simple, miniature robotic guidance and positioning system, as well as on fast and accurate image processing tools.

Medigus (TASE: MDGS) is developing endoscopy systems for the treatment of GERD (Gastro Esophageal Reflex Disease) and other diseases of the digestive system.

Optonol develops, manufactures, and sells the Ex-PRESSTM microscopic glaucoma shunt family of products, offering a superior solution for glaucoma filtering surgery.